Intervention not reported
Gross motor function related to walking, running and jumping (GMFM) ‐ Dimension E (%) · children under six years with cerebral palsy or Down syndrome or at risk of neuromotor delay
1 finding from 1 review
Functional capacity · COPD
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Walking at postoperative day 1 Objective actual measurement · adults undergoing elective primary total hip replacement
It is very uncertain whether peripheral nerve blocks changes walking at postoperative day 1 Objective actual measurement compared with systemic analgesia (very low certainty).
1 finding from 1 review
Intervention not reported
Walking distance (end of · patients with diffuse emphysema
1 finding from 1 review
Change in 10‐metre walking time · patients with Duchenne muscular dystrophy
1 finding from 1 review
Change in 10‐metre walking time · patients with Duchenne muscular dystrophy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Nine‐metre walking/running time: prednisone ‐ daily dose regimen (0.75 mg/kg/day) · patients with Duchenne muscular dystrophy
1 finding from 1 review
Change in 6‐minute walking distance · post‐exacerbation COPD
1 finding from 1 review
Intervention not reported
Walking distance: change from baseline · people with stroke
The intervention showed no clear difference in walking distance: change from baseline (moderate certainty).
1 finding from 1 review
Intervention not reported
Walking speed · people with stroke
The intervention showed no clear difference in walking speed (low certainty).
1 finding from 1 review
Pain‐free walking distance · people with symptomatic intermittent claudication
1 finding from 1 review
Change in maximum walking distance (MWD) · people with symptomatic intermittent claudication
1 finding from 1 review
Exercise performance ‐ walking distance 6MWT, ISWT, ESWT · adults with advanced disease for muscle weakness
1 finding from 1 review
Activity Gait speed · people with stroke
1 finding from 1 review
walking distance in m (at the end of study; all studies) ‐ Active control group (co‐interventions were similar in both groups) Measures of timed gait. Scale from: 0 to inf. · people with stroke
1 finding from 1 review
Intervention not reported
Pain on walking (VAS) Scale from 0 to 10 · patients with varus medial osteoarthritis of the knee
1 finding from 1 review
Intervention not reported
Pain on walking (NRS) Scale from 0 to 10 · patients with varus medial osteoarthritis of the knee
1 finding from 1 review
walking distance in m (at the end of study; all studies) ‐ Active control group (co‐interventions were similar in both groups) Measures of timed gait. Scale from: 0 to inf. · people with Parkinson's disease
2 findings from 1 review
Community Walk Test Community walk test (time multiplied by level of walking aid) · adult stroke survivors
1 finding from 1 review
Walking ability · adult stroke survivors
1 finding from 1 review